Clinical Trial

Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer

Study acronym: KOV-02S
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To compare outcomes between the CRS group and the control group in patients with recurrent epithelial ovarian cancer who have undergone chemotherapy
Trial Details
NCT Number NCT07171528
Lead Sponsor National Cancer Center, Korea
Conditions Ovarian Cancer
Enrollment 80 participants
Start Date 2025-09-10
Primary Completion 2027-12-31 (estimated)
Study Completion 2033-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-12